Tailormade CRISPR-Based Solutions for Therapeutic Applications
Time: 9:00 am
day: Day One
Details:
- Emendo’s nuclease discovery and protein engineering platforms facilitate the development of the optimal editing strategy for each indication
- Nucleases with unique PAM sequences allow for targeting exclusive genomic sites
- Discovery of nucleases of various characteristics enables flexibility in choosing delivery vehicles
